Table of Contents
What changed
Revenue from continuing operations declined 10.7% to NZ$296.5m, yet profit before tax rose 28.6% to NZ$37.4m and NPAT rose 28.2% to NZ$26.9m on a stable effective tax rate of about 28.1%. The earnings lift came from segment margin, not volume: Finance operating margin expanded to roughly 33.0% (from 26.6%), Insurance to 22.3% (from 14.1%), and Automotive retail to 7.7% (from 6.1%). Credit management revenue fell 28.9% and its result declined accordingly.
The balance sheet changed shape dramatically. Total assets rose 98.3% to NZ$718.5m and gross borrowings rose 94.3% to NZ$339.6m, while equity grew 79.9% to NZ$233.6m. Cash fell 63.8% to NZ$11.9m, taking net debt to NZ$327.7m from NZ$142.0m. Operating cash inflow recovered to NZ$10.9m from roughly breakeven, and capex almost halved to NZ$8.6m, leaving pre-lease free cash flow of NZ$2.2m. A final dividend of 6.0 cps was declared.
What matters
- Mix, not top-line, drove the result. Automotive retail is still roughly two-thirds of segment revenue, but Finance and Insurance delivered the bulk of the earnings uplift through margin expansion. This is a more capital-intensive earnings base than the prior year mix implies.
- Balance-sheet expansion dominates the read. Total assets and borrowings roughly doubled, and equity grew 79.9%. The provided excerpts do not explain the step-up, but the scale is consistent with consolidation of a finance book rather than organic growth; this needs direct confirmation from the filing.
- Return on equity fell to 11.5% from 16.1% despite higher NPAT, because the equity base grew faster than earnings. Leverage direction is weakening on a gross basis, with net debt more than doubled.
Expectations
No FY22 target, forward-work metric, or formal guidance was disclosed in the provided excerpts. The prior-year commentary referenced a pre-COVID NPBT guidance range of NZ$28m–NZ$30m, and FY21 PBT of NZ$37.4m sits well above that prior band. Seasonality context from HY21 (labelled HY20 in the extraction) shows 47.6% of revenue and 50.0% of NPAT fell in the first half, so the year was only modestly second-half weighted; there is no hidden late-year acceleration to rely on.
Quality of result
The earnings result is clean at the tax line — PBT and NPAT grew within 0.4pp of each other, and there is no disclosed non-recurring item or discontinued operation driver in the excerpts. However, several elements temper the read on durability:
- Cash conversion lags earnings materially. Pre-lease FCF of NZ$2.2m represents just 8.3% of NPAT. Inventory rose 113.3% to NZ$30.2m, lifting inventory days from 15.6 to 37.1, which absorbed working capital and was a meaningful drag.
- Cash balance fell NZ$20.9m even as borrowings rose NZ$164.8m, suggesting the proceeds were deployed rather than retained.
- Segment margin gains in Finance and Insurance look structural on this one-period read, but no like-for-like commentary or non-GAAP reconciliation was provided to separate underlying performance from provisioning, portfolio acquisition timing, or one-off insurance claim experience.
The declared 6.0 cps final dividend implies roughly 19.1% payout against NPAT but is not covered by pre-lease FCF on current-year cash generation.
Unresolved
- What drove the near-doubling of total assets, borrowings, and equity? The excerpts do not name an acquisition, consolidation of a previously equity-accounted finance vehicle, or a capital raise, yet the scale of change implies one of these.
- Why did Credit management revenue fall 28.9% while other segments were broadly resilient?
- What is the composition of the NZ$339.6m borrowings — operating funding versus finance-receivables funding — and therefore the true economic net debt against shareholders rather than against a match-funded receivables book?
- Why did inventory build to NZ$30.2m, and is this positioning for demand or a sell-through issue?
- Total net profit of NZ$27.5m exceeds continuing NPAT of NZ$26.9m, but no breakdown of the NZ$0.6m difference was provided.
This briefing cannot assess whether the balance-sheet expansion reflects an acquisition, a finance-book consolidation, or organic funding growth, because the driver is not disclosed in the supplied excerpts.
Key metrics
| Metric | FY20 | FY20 | Change |
|---|---|---|---|
| Revenue | $296.5m | $332.2m | -10.7% ↓ |
| Net profit after tax | $26.9m | $21.0m | +28.2% ↑ |
| Net cash inflow from operating activities | $10.9m | −$0.0m | +34093.8% ↑ |
| Final dividend per share | 6.0c | — | — |
| Profit before tax | $37.4m | $29.1m | +28.6% ↑ |
| Cash and cash equivalents | $11.9m | $32.8m | -63.8% ↓ |
| Total assets | $718.5m | $362.3m | +98.3% ↑ |
Reference: annolyse.ai/briefings/tra-fy20
Segment breakdown
| Segment | Current revenue | Prior revenue | Current result | Mix shift |
|---|---|---|---|---|
| Automotive retail | $200.9m | $224.9m | $15.4m | -1.4pp |
| Finance | $47.9m | $45.7m | $15.8m | +2.0pp |
| Credit management | $12.8m | $17.9m | $5.1m | -1.2pp |
| Insurance | $41.9m | $44.1m | $9.3m | +0.5pp |
| Corporate & other | $0.1m | $0.0m | −$8.3m | +0.0pp |
Reference: annolyse.ai/briefings/tra-fy20
Analytical metrics
| Metric | FY20 | FY20 | Context |
|---|---|---|---|
| PBT growth | +28.6% | — | — |
| Effective tax rate | 28.1% | 27.9% | — |
| FCF pre-lease | $2.2m | −$19.3m | +$21.5m |
| FCF / NPAT | 8.3% | -92.0% | complementary conversion metric |
| Capex % revenue | 2.9% | 5.8% | — |
| Capex | −$8.6m | −$19.2m | +$10.6m |
| Debtor days | 8.8 | 9.5 | -0.6 days |
| Inventory days | 37.1 | 15.6 | +21.6 days |
| Operating working capital | $37.3m | $22.8m | +$14.6m absorbed |
| Trade debtors | $7.2m | $8.6m | −$1.5m |
| Net debt | $327.7m | $142.0m | +$185.7m |
| Gross borrowings | $339.6m | $174.8m | +$164.8m |
| Payout ratio vs NPAT | 19.1% | — | — |
| Payout ratio vs FCF pre-lease | 229.5% | — | not covered |
| ROE (annualised) | 11.5% | 16.1% | Weakening |
| HY20 share of FY21 revenue | 47.6% | — | Other half was 52.4% |
| HY20 share of FY21 NPAT | 50.0% | — | Other half was 50.0% |
| Profit from continuing operations | $26.9m | $21.0m | +$5.9m |
Reference: annolyse.ai/briefings/tra-fy20
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.